[1] |
HU Li, YANG Weifeng, LIU Ting, FENG Weihong, LU Chenna, LI Chun.
Research progress on the mechanism of action and drugs of FXR in the treatment of cholestatic liver diseases
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1184-1191.
|
[2] |
SUN Shaowei, LIN Tingting, WEI Chuanmei, LYU Wenwen, SONG Zheng.
Pharmaceutical Care of a Patient with HBV Infection after Second Renal Transplantation
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 689-692.
|
[3] |
WANG Xiaoxiao, CHEN Wanyi.
Pharmaceutical Monitoring of Immunohepatitis Caused by PD-L1 Inhibitor: a Case Study
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 693-696.
|
[4] |
GAI Xing-wen, MA Yong, ZHANG Wen-xue.
Clinical Observation of Alprostadil Injection in Treatment of Patients with Decompensated Hepatitis B Cirrhosis
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(9): 525-528.
|
[5] |
.
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(3): 187-187.
|
[6] |
.
[J]. Chinese Journal of Pharmacovigilance, 2014, 11(1): 57-58.
|
[7] |
.
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(12): 768-768.
|
[8] |
.
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(10): 639-639.
|
[9] |
YIN Cheng-xia.
Literature Analysis of 55 Cases of Adverse Drug Reaction by Glucoside Tripterygium Total
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(8): 478-482.
|
[10] |
SUN Hua ,YU Ling-Hong ,WEI Huai-Ling ,ZHANG Dan .
Effects of Bicyclol on the Inhibition of Gap Junctional Intercellular Communication by DDT in WB-F344 Cells
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(7): 385-389.
|
[11] |
REN Li-jie ,YU Ping, XU Zuo-guo.
Analysis of 35 Cases of Adverse Drug Reaction Induced by Intra-oral Medication
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(7): 421-423.
|
[12] |
LUO Qing-feng ,YE Cheng-hong, DENG Jie .
Analysis of Adverse Events of Tracheostomy Tube and Imported Products Recall
[J]. Chinese Journal of Pharmacovigilance, 2013, 10(7): 435-437.
|